TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Focusing on a medical representative transformation: may not sell drugs Also really tube tightly
 
Author:中国铭铉 企划部  Release Time:2017-4-11 9:49:29  Number Browse:551
 
Medical network - April 11 state issued by the relevant opinions, to purify the medicine representative team, improve the drug circulation market related problems, put forward clear requirements. 
 
Experts believe that ought to be in setting allows a medical representative to exercise information exchange on duties, it is forbidden to contact funds and warehousing and distribution; Encourage the real academic conference, false academic true giving is prohibited. At the same time also need to form a complete set of comprehensive reform measures, such as reforming the doctor pay system, strengthen professional management, industry, etc. 
 
Drug prices artificially high, drug kickbacks, commercial bribery, in people's impression, the grey words seem to cannot leave the figure of medical representative. 
 
Recently, the state issued by the opinion is put forward, "a medical representative only academic promotion, technical consulting and other activities, shall not be responsible for drug sales". Medicine circulation of two votes plus a medical representative records, as well as more and more the price reduction measure, the synthetical effects of the various policy, will leads to the transformation of the medical representative what? The reporter interviewed the national center for health development planning commission health development research researcher Fu Hongpeng and vertical and horizontal consultants hong-zhi wang at Peking University. 
 
Ask marketing and promotion, how to distinguish between good 
 
That post set the difference between the two drugs with money and warehousing and distribution 
 
Reporter: how to define the boundaries of selling and promotion? How to regulate? 
 
Fu Hongpeng: difficult to differentiate the absolute between academic promotion and marketing, said in the file is a medical representative shall not bear the sales task, it can be distinguished from the internal assessment of post setting and open, also can regulation, regulation of course is difficult. Look from the behavior, the drug marketing is main characteristics with gold sales rebates and disguised bribes. Emphasis on the promotion, the main is to prohibit kickbacks bribes to promote sales. On the other hand, if it's academic activities, including costs also have a standard, can carry out the audit. 
 
Hong-zhi wang: shall not be responsible for drug sales have two kinds of understanding, one from the Angle of responsibility, a complete sales must be at least the exchange of information, capital and logistics. Pharmaceutical sales representative shall not bear the tasks can be understood as a medical representative can only exercise the information exchange duty (technical service and consulting), but not with money and warehousing distribution, equivalent to a supermarket promoters. In accordance with the relevant laws, a medical representative should bear the responsibility, but some use reserve agency model of so-called medical representative, is the money exchange and storage and distribution of responsibility at the same time, these phenomena should be ban can also. Another is from the perspective of the performance management shall not bear the sales tasks can be understood as a medical representative of performance appraisal is not linked to how much drug sales. If understanding from this Angle, shall not be responsible for drug sales is difficult to regulation. 
 
Reporter: in the past some academic conferences, activities, the objective is to sell medicine, don't let a medical representative selling medicine now, then how such meetings, activities, also held? 
 
Fu Hongpeng: the ultimate goal and the goal of individual activities should be the difference between a, at least direct effects and indirect effects of different, the new rules ban academic activities, I don't think so but prohibited under the name of the academic red envelopes of bribery, etc., with the gold sales. Should hold the academic exchange can be normal, but the doctor JiangKeFei, labor, and travel expenses shall be paid according to standards of academic activities. 
 
Hong-zhi wang: the early reform and opening up, the doctor's knowledge update mainly comes from the medicine representative, to popularize knowledge of medicine, medical representatives doctor to guide rational drug use, has played a good role. Now some enterprises under the academic conference, access, disguised in the name of tourism to take gold sales, this policy is not allowed. Aid doctors academic conference should not how many hang jun and drug dosage, real academic conference should be encouraged. 
 
Ask medicine generation don't sell drugs, drug prices will fall 
 
May not directly lead to drug prices fall, reform needs comprehensive measures 
 
Reporter: a medical representative can't sell drugs, drug prices will fall? 
 
Fu Hongpeng: the dynamic perspective, the cost reduced, but the enterprise may be disguised in other way, is adding to the cost. Drug prices return to a normal need to see if comprehensive management measures. From a single policy point of view, this rule can reduce the cost of had existed before, cut off the gray trading in the current chain, in particular, to boost drug is a reasonable price. 
 
Reporter: public hospitals to cancel the drug addition, this year will also promote the drug circulation of two votes, and now don't let a medical representative to sell medicine, doctors can't get the income, the hospital has a big income less, how to develop after hospital? On the one hand is to establish a doctor reasonable salary system, drug prices dropped on the other hand, will the other charge came up, the doctor fee or not fall down? 
 
Fu Hongpeng: all of these problems may exist. Drugs is only one hospital revenue channels, drugs have less income, and other medical service income, government subsidies, etc., of course also affects the doctor income. Public hospital comprehensive reform is essential, therefore, the hospital compensation mechanism, medical personnel salary system, distribution system, management system and so on all need to plan as a whole, comprehensive reform. 
 
Hong-zhi wang: whether a medical representative can only be engaged in technical consultation, or a medical representative performance appraisal is not linked to sales, even can do may not directly lead to drug prices fall, reform needs comprehensive measures. Part of the current drug kickbacks became part of the doctor income, prices drop, this part inevitably affect the enthusiasm of the doctor, this need to solve with salary system reform of hospital. 
 
Salary system reform is the key to the reform, recently, four departments on the salary system reform of public hospitals will be carried out pilot work guidance "issued by the, clear" allows the regulation and control of medical and health institutions to break through the current institution wage, allow the medical service revenue after deducting costs and in accordance with the provisions, extraction of various funds is mainly used for personnel rewards ", "in the independent distribution" within the amount of compensation for approval. Salary system reform of funds from the bird in a cage to drug prices fall, part of the service price, in order to form a doctor reasonable income level. It is more reasonable than receiving kickbacks to get income and more efficient, more in line with industry law of development. 
 
In addition, as well as our country Taiwan area from abroad experience, should use the way of government leading, market mechanism, such as use to push the payment reform, form a reasonable salary system, rather than relying more on administrative means, thus reducing the rebate existing space. 
 
q If you don't sell drugs, medicine generation do 
 
An existence value, from relational to the technical transformation 
 
Reporter: at present the national probably how many medical representative? Don't do after sales, if they are out of work? 
 
Fu Hongpeng: the number of deputies to the national medicine there is no official statistics, according to the statistical standard is different, there are 100 and 3 million. 
 
Hong-zhi wang: this profession still have value, medical representatives drug technical services, consulting, or need. Past medical representative is mainly engaged in developing and maintaining relationships with hospital doctors (relational), transaction (deal) with hospital doctors, along with the advancement of health care, medical representatives from "relational" and "transaction type" to "technical". 
 
Reporter: the other countries how to manage a medical representative? They have any good experience to prevent a medical representative and gray transactions between hospital? 
 
Fu Hongpeng: many countries have drug marketing or sales specification, emphasis is a medical representative can only introduce product efficacy and method of use, shall not be further interference doctor decisions. Another is to the enterprise heavy penalties, doctors scrutiny. There is a doctor's salary is reasonable, and occupation, industry management is strict, receive red envelopes do more harm than good. Social environment of fresh air wind is also have very big effect. As we look at the Hong Kong experience, the other party is not just a "dare not corrupt", and has reached the point of "don't want to rot". 
 
Hong-zhi wang: in some developed countries drug firms selling strictly regulation, legal norms and can offer huge fines, the high cost of illegal drug firms will be in accordance with the law to manage more than it was heavy, enterprise interior is equipped with special audits of compliance department. It is worthy of reference for our country. 
 
Previous article:Sichuan: 25 drug false quotes in bad record Play to the market
Next article:Shenzhen pilot reform of public hospital pharmaceutical group has made three changes
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号